Physicians' Academy for Cardiovascular Education

Statins, safety and compliance: Dealing with side effects

Slides (presentation) - Oct. 17, 2009

Statins, safety and compliance: Dealing with side effects

Peter J. Lansberg MD, PhD

Department of Vascular Medicine, Academic Medical Center,

Amsterdam, The Netherlands

View presentation, click on slides

J-LIT Japanese Lipid Intervention Trial
MEGA Management of Elevated Cholesterol in the Primary Prevention of Adult Japanese
Statin Tolerability and Perceived Risk for Adverse Events
The National Lipid Association Statin Safety Task Force Report
Questions about Liver Issues in Statin-Taking Patients
Transaminases and Liver Disease
The Incidence of Elevated Liver Biochemistries Over a 6-Month Period Among Statin Users Predominantly Atorvastatin and Simvastatin
Use of Simvastatin in Patients with Hepatitis C
Statin Tolerability and Safety – Liver Effects
Questions about Muscle Issues in Statin-Taking Patients
Reported cases of fatal rhabdomyolysis per number of prescriptions for HMG-CoA reductase inhibitors(statins) dispensed in the US from launches to May 2001
Rhabdomyolysis Reports as a percentage of the Total AEs on the FDA Database
Factors that Increase the Risk of Statin Induced Myopathy
Strategies to Improve Patient compliance

Share this page with your colleagues and friends: